Riskpilot← Back to searchSign inGet full accessBÆRUMSKLINIKKEN AS
ASActiveOrg 994104195Brodtkorbsgate 7, 1338 SandvikaGeneral medical practice activities · NACE 8621Est. 20095 employees
Revenue 2025
NOK 3,1M
+7% vs 2024
EBITDA margin
4.2%
+181% vs 2024
Equity ratio
-72.5%
Financial strength
Net profit 2025
NOK 70K
+131% vs 2024
| Revenue | NOK 3,1M | +7% |
| EBITDA | NOK 131K | +181% |
| Net profit | NOK 70K | +131% |
| Total assets | NOK 121K | -32% |
| Equity | NOK -87K | +44% |
| Employees | 5 | — |
Legal name
BÆRUMSKLINIKKEN AS
Org number
994104195
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
20. mai 2009
Share capital
NOK 100 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Kontorfellesskap for leger som jobber i og er tilknyttet selskapet
Address
Brodtkorbsgate 7, 1338 Sandvika
Phone
+4767804700
Email
post@wtw.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 850 | 2 772 | 3 039 | 2 880 | 3 090 |
| Staff expenses | −1 423 | −1 461 | −1 576 | −1 597 | −1 385 |
| EBITDA | 186 | 28 | 105 | −162 | 131 |
| Depreciation & amort. | −14 | −17 | −35 | −50 | −52 |
| EBIT | 172 | 10 | 70 | −212 | 79 |
| Net financials | −3 | −17 | −12 | −11 | −9 |
| Profit before tax | 169 | −6 | 57 | −223 | 70 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 169 | −6 | 57 | −223 | 70 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 411 | 427 | 402 | 177 | 121 |
| Equity | 15 | 8 | 66 | −157 | −87 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 396 | 419 | 337 | 335 | 208 |
| Total debt | 396 | 419 | 337 | 335 | 208 |
EBITDA margin
4.2%
This company
15.8%
Market median
-73% vs market
20212025
Equity ratio
-72.5%
This company
38.2%
Market median
-290% vs market
20212025
Return on equity
7001800.0%
This company
18.4%
Market median
+38053161% vs market
20212025
Net profit margin
2.3%
This company
8.1%
Market median
-72% vs market
20212025
Asset turnover
25.64×
This company
1.12×
Market median
+2189% vs market
20212025
Debt / equity
2.38×
This company
0.62×
Market median
-284% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EN Chief Executive Officer | Chief Executive Officer | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Chairman | 2023 – 2024 | |
| Deputy Chairman | 2018 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 34% | 34% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BÆRUMSKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Nymoen | Chief Executive Officer | 0 companies |
| Vibeke Løvdal | Chairman | 0 companies |
| Daniel Andreas Olsen Harvei | Chairman | 0 companies |
| Arman Hadzic | Board of Directors | 0 companies |
| Dominika Brattlund Klein | Deputy Chairman | 0 companies |